Trials for Mental Health & Substance Use

Clinical trials for mental health, behavioral health and substance use treatments have unique challenges. Adults with disorders such as bi-polar, schizophrenia, PTSD and depression tend to inherently have difficulty with medication adherence. Adults that use controlled substances often struggle with addiction. This makes medication compliance in a clinical trial more fraught with risk. CuePath can address the concerns that a Principal Investigator may have when conducting a clinical trial for a mental health disorder treatment or for a controlled substance replacement drug.

Improve patient safety: CuePath can help improve patient safety by monitoring patients for non-compliant behaviors such as taking larger doses that prescribed, and potentially risking an overdose situation. For some controlled substances, doses are reduced over the trial period. CuePath is able to monitor whether the participant is tapering, or if additional support is needed.

Mitigate risk of diversion: Clinical trials for substance use and addiction come with a unique set of challenges. Some participants may not have a fixed address. They are prone to abandon the clinical trial before completion. Self-reporting of compliance is highly unreliable. Diversion is also a significant risk. CuePath enables researchers to identify participants that exhibit non-compliant behaviors that might indicate diversion so the Investigator can take the appropriate action.

Ensure ethical considerations: CuePath can help ensure that the trial is conducted in an ethical manner by providing patients with clear information about monitoring of medications, informed consent, and privacy protections.

CuePath can help address the above concerns of a Principal Investigator conducting a clinical trial in the areas of mental health and substance use. By leveraging technology to support patient care and data collection, an Investigator can optimize the success of the trial while prioritizing patient safety and well-being.